Xmd17-109

SynDRA canonical compound SYN1334216 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	LRRK2 \| MAPK7
Mechanism of action	MAP kinase inhibitor

All known targets

MAPK7

Mechanisms of action (all sources)

MAPK7 INHIBITOR

Cross-references

PubChem CID: 71604307
ChEMBL: CHEMBL2381340
PDB: VYJ

Synonyms

compound 26 [PMID: 24239623]
compound 26 (PMID: 24239623)
RefChem:902371
ERK5-IN-1
C36H46N8O3
VYJ
GTPL9406
orb1307343
SCHEMBL16065687
SCHEMBL29375286
SCHEMBL29538109
GLXC-90052
EX-A2184
KHC48837
BDBM50434070
s7334
AKOS025147359
CCG-270311
CS-1436
SB19431
XMD17-109?
NCGC00378965-02
NCGC00378965-03
AC-35970
BS-15121
HY-15665
D71043
BRD-K48449981-001-01-9
BRD-K48449981-001-02-7

Look up Xmd17-109 in the interactive SynDRA portal →